1. Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system.
- Author
-
Han, Seung-Soo, Lee, Jinjoo, Jung, Yideul, Kang, Myeong-Ho, Hong, Jung-Hyub, Cha, Min-Suk, Park, Yu-Jin, Lee, Ezra, Yoon, Cheol-Hee, and Bae, Yong-Soo
- Subjects
- *
POLIOVIRUS , *GENETIC vectors , *RECOMBINANT viruses , *VIRAL vaccines , *DRUG dosage - Abstract
We developed a CTL vaccine vector by modification of the RPS-Vax system, a mucosal vaccine vector derived from a poliovirus Sabin 1 strain, and generated an oral CTL vaccine against HIV-1. A DNA fragment encoding a cytoplasmic transduction peptide (CTP) was integrated into the RPS-Vax system to generate RPS-CTP, a CTL vaccine vector. An HIV-1 p24 cDNA fragment was introduced into the RPS-CTP vector system and a recombinant poliovirus (rec-PV) named vRPS-CTP/p24 was produced. vRPS-CTP/p24 was genetically stable and efficiently induced Th1 immunity and p24-specific CTLs in immunized poliovirus receptor-transgenic (PVR-Tg) mice. In challenge experiments, PVR-Tg mice that were pre-immunized orally with vRPS-CTP/p24 were resistant to challenge with a lethal dose of p24-expressing recombinant vaccinia virus (rMVA-p24). These results suggested that the RPS-CTP vector system had potential for developing oral CTL vaccines against infectious diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF